Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOMIR Service is a Russian biotechnology company founded in 2000 that specializes in tissue engineering and regenerative medicine. The company develops and manufactures innovative biomimetic products, most notably the SpheroGEL heterogeneous implantable gel and the ElastoPOB biopolymer membrane, which are designed to mimic the extracellular matrix and stimulate natural tissue repair. These products are utilized across a wide range of clinical applications, including surgery, ophthalmology, and traumatology, to restore the morphological and functional properties of damaged tissues. BIOMIR Service operates in close collaboration with leading scientific institutions, such as the Shumakov National Medical Research Center of Transplantology and Artificial Organs, to advance the field of bioengineered cellular products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOMIR service.